CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | Wise John Drayton Chief Commercial Officer | Exercise or conversion 10b5-1 | +10,000 | $16.07 | $161K | 132,492 |
| 2025-01-07 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −10,000 | $65.98 | $660K | 122,492 |
| 2025-01-07 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −2,908 | $65.87 | $192K | 119,584 |
| 2025-01-07 | Wise John Drayton Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2025-01-07 | Lewis William Chair and CEO | Sale | −8,218 | $66.02 | $543K | 376,742 |
| 2025-01-07 | Smith Michael Alexander Chief Legal Officer | Sale | −2,306 | $65.98 | $152K | 65,642 |
| 2025-01-07 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −2,444 | $65.95 | $161K | 147,666 |
| 2025-01-02 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +18,750 | $22.76 | $427K | 403,710 |
| 2025-01-02 | Lewis William Chair and CEO | Sale 10b5-1 | −18,750 | $69.84 | $1.3M | 384,960 |
| 2025-01-02 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-01-02 | Lewis William Chair and CEO | Sale 10b5-1 | −6,830 | $69.86 | $477K | 233,924 |
| 2025-01-02 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 93,750 | ||
| 2025-01-02 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 225,460 | ||
| 2024-12-19 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +18,750 | $22.76 | $427K | 403,710 |
| 2024-12-19 | Lewis William Chair and CEO | Sale 10b5-1 | −13,162 | $69.65 | $917K | 390,548 |
| 2024-12-19 | Lewis William Chair and CEO | Sale 10b5-1 | −5,588 | $70.52 | $394K | 384,960 |
| 2024-12-19 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2024-12-19 | Lewis William Chair and CEO | Sale 10b5-1 | −5,240 | $69.71 | $365K | 235,514 |
| 2024-12-19 | Lewis William Chair and CEO | Sale 10b5-1 | −1,590 | $70.61 | $112K | 233,924 |
| 2024-12-19 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 112,500 |
Page 34 of 42 · 826 trades